Recent Updates
Recently added Catalysts
ECOR Positive Sentiment

electroCore to Participate at Annual Aegis Virtual Conference

Monday, May 1, 2023 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: electroCore, Inc. has announced that its CEO, Dan Goldberger, will present at the Annual Aegis Virtual Conference scheduled for May 2-4, 2023. The company specializes in bioelectronic medicine, focusing on non-invasive vagus nerve stimulation (nVNS) technology. The conference represents an opportunity for electroCore to enhance its visibility and engage with industry stakeholders. The company aims to improve health management through its innovative medical devices and consumer products.
Price reaction · baseline $6.1394 (2023-04-28 close) · 1 other ECOR headline(s) in the window, move may be shared
day 0 close · peak
-2.3%

Market Sentiment Analysis

POSITIVE FACTORS

  • Presentation at a notable industry conference showcases company visibility.
  • Focus on innovation in bioelectronic medicine highlights potential growth.
  • Presence of CEO Dan Goldberger emphasizes leadership commitment.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~7 mo
High dilution risk
Lead asset
GammaCore
Phase 2 · Chronic Cluster Headache

Full Press Release Details

ROCKAWAY, N.J., May 01, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR) a commercial-stage bioelectronic medicine and wellness company, today announced that electroCore’s Chief Executive Officer, Dan Goldberger, will present at the Annual Aegis Virtual Conference being held May 2-4, 2023.
Aegis Capital Conference:
Date: Tuesday, May 2, 2023
Event: Presentation here
About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company dedicated to improving health through its non-invasive vagus nerve stimulation (“nVNS”) technology platform. Our focus is the commercialization of medical devices for the management and treatment of certain medical conditions and consumer product offerings utilizing nVNS to promote general wellbeing and human performance in the United States and select overseas markets.
For more information, visit www.electrocore.com.

Frequently Asked Questions

When is electroCore presenting at the Aegis Conference?

electroCore will present on May 2, 2023, at the Aegis Virtual Conference.

What technology does electroCore specialize in?

electroCore specializes in non-invasive vagus nerve stimulation (nVNS) technology.

What is the focus of electroCore's operations?

electroCore focuses on commercializing medical devices and consumer products using nVNS.

Where does electroCore operate its services?

electroCore operates in the United States and select international markets.

ShareAdd on Google
Tags: ECOR Viatris Investor Conferences Healthcare bioelectronic medicine Aegis Capital Conference vagus nerve stimulation medical devices
Last updated: May 1, 2023

Biotech snapshot

Cash runway
$10M liquidity · $1M/mo burn
~7 mo
High dilution risk
Lead asset
GammaCorePhase 2
Chronic Cluster Headache →